Annual Total Long Term Liabilities
$694.90 M
-$254.78 M-26.83%
December 31, 2024
Summary
- As of March 12, 2025, PACB annual total long term liabilities is $694.90 million, with the most recent change of -$254.78 million (-26.83%) on December 31, 2024.
- During the last 3 years, PACB annual total long term liabilities has fallen by -$449.37 million (-39.27%).
- PACB annual total long term liabilities is now -39.27% below its all-time high of $1.14 billion, reached on December 31, 2021.
Performance
PACB Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$694.90 M
-$242.03 M-25.83%
December 31, 2024
Summary
- As of March 12, 2025, PACB quarterly total long term liabilities is $694.90 million, with the most recent change of -$242.03 million (-25.83%) on December 31, 2024.
- Over the past year, PACB quarterly long term liabilities has dropped by -$242.03 million (-25.83%).
- PACB quarterly long term liabilities is now -39.27% below its all-time high of $1.14 billion, reached on December 31, 2021.
Performance
PACB Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
PACB Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -26.8% | -25.8% |
| 3 y3 years | -39.3% | -25.8% |
| 5 y5 years | +1482.4% | -25.8% |
PACB Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -39.3% | at low | -39.3% | at low |
| 5 y | 5-year | -39.3% | +1637.8% | -39.3% | +1637.8% |
| alltime | all time | -39.3% | >+9999.0% | -39.3% | >+9999.0% |
Pacific Biosciences Of California Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $694.90 M(-26.8%) | $694.90 M(-25.8%) |
| Sep 2024 | - | $936.93 M(-0.2%) |
| Jun 2024 | - | $938.40 M(-1.0%) |
| Mar 2024 | - | $947.95 M(-0.2%) |
| Dec 2023 | $949.68 M(+0.9%) | $949.68 M(-0.1%) |
| Sep 2023 | - | $950.65 M(+1.8%) |
| Jun 2023 | - | $934.22 M(-0.5%) |
| Mar 2023 | - | $938.63 M(-0.2%) |
| Dec 2022 | $940.85 M(-17.8%) | $940.85 M(-15.3%) |
| Sep 2022 | - | $1.11 B(+0.1%) |
| Jun 2022 | - | $1.11 B(-2.7%) |
| Mar 2022 | - | $1.14 B(-0.3%) |
| Dec 2021 | $1.14 B(+2761.6%) | $1.14 B(+0.6%) |
| Sep 2021 | - | $1.14 B(+20.8%) |
| Jun 2021 | - | $942.10 M(+0.4%) |
| Mar 2021 | - | $938.60 M(+2247.3%) |
| Dec 2020 | $39.99 M(-8.9%) | $39.99 M(-1.4%) |
| Sep 2020 | - | $40.55 M(-2.0%) |
| Jun 2020 | - | $41.39 M(-2.3%) |
| Mar 2020 | - | $42.39 M(-3.5%) |
| Dec 2019 | $43.91 M(+49.7%) | $43.91 M(-1.1%) |
| Sep 2019 | - | $44.40 M(-2.1%) |
| Jun 2019 | - | $45.38 M(-0.6%) |
| Mar 2019 | - | $45.63 M(+55.6%) |
| Dec 2018 | $29.33 M(-0.1%) | $29.33 M(-0.2%) |
| Sep 2018 | - | $29.38 M(+0.2%) |
| Jun 2018 | - | $29.32 M(+0.2%) |
| Mar 2018 | - | $29.26 M(-0.3%) |
| Dec 2017 | $29.35 M | $29.35 M(+12.0%) |
| Sep 2017 | - | $26.20 M(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $26.35 M(-14.7%) |
| Mar 2017 | - | $30.88 M(+58.8%) |
| Dec 2016 | $19.44 M(+0.3%) | $19.44 M(-2.1%) |
| Sep 2016 | - | $19.85 M(+1.8%) |
| Jun 2016 | - | $19.49 M(+0.5%) |
| Mar 2016 | - | $19.39 M(0.0%) |
| Dec 2015 | $19.39 M(-48.9%) | $19.39 M(-1.3%) |
| Sep 2015 | - | $19.65 M(-17.8%) |
| Jun 2015 | - | $23.92 M(-13.1%) |
| Mar 2015 | - | $27.54 M(-27.4%) |
| Dec 2014 | $37.95 M(-14.6%) | $37.95 M(-3.8%) |
| Sep 2014 | - | $39.47 M(-4.3%) |
| Jun 2014 | - | $41.26 M(-4.1%) |
| Mar 2014 | - | $43.00 M(-3.3%) |
| Dec 2013 | $44.45 M(+699.7%) | $44.45 M(-5.0%) |
| Sep 2013 | - | $46.78 M(+149.0%) |
| Jun 2013 | - | $18.79 M(-1.7%) |
| Mar 2013 | - | $19.10 M(+243.7%) |
| Dec 2012 | $5.56 M(-25.7%) | $5.56 M(-8.1%) |
| Sep 2012 | - | $6.04 M(-11.1%) |
| Jun 2012 | - | $6.80 M(-3.4%) |
| Mar 2012 | - | $7.04 M(-5.9%) |
| Dec 2011 | $7.48 M(+48.3%) | $7.48 M(+21.7%) |
| Sep 2011 | - | $6.14 M(-4.4%) |
| Jun 2011 | - | $6.43 M(+11.7%) |
| Mar 2011 | - | $5.75 M(+14.2%) |
| Dec 2010 | $5.04 M(-98.1%) | $5.04 M(-98.7%) |
| Sep 2010 | - | $380.32 M(+7331.1%) |
| Jun 2010 | - | $5.12 M(-98.1%) |
| Dec 2009 | $269.80 M(+33.7%) | $269.80 M |
| Dec 2008 | $201.79 M | - |
FAQ
- What is Pacific Biosciences of California annual total long term liabilities?
- What is the all time high annual total long term liabilities for Pacific Biosciences of California?
- What is Pacific Biosciences of California annual total long term liabilities year-on-year change?
- What is Pacific Biosciences of California quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Pacific Biosciences of California?
- What is Pacific Biosciences of California quarterly long term liabilities year-on-year change?
What is Pacific Biosciences of California annual total long term liabilities?
The current annual total long term liabilities of PACB is $694.90 M
What is the all time high annual total long term liabilities for Pacific Biosciences of California?
Pacific Biosciences of California all-time high annual total long term liabilities is $1.14 B
What is Pacific Biosciences of California annual total long term liabilities year-on-year change?
Over the past year, PACB annual total long term liabilities has changed by -$254.78 M (-26.83%)
What is Pacific Biosciences of California quarterly total long term liabilities?
The current quarterly long term liabilities of PACB is $694.90 M
What is the all time high quarterly long term liabilities for Pacific Biosciences of California?
Pacific Biosciences of California all-time high quarterly total long term liabilities is $1.14 B
What is Pacific Biosciences of California quarterly long term liabilities year-on-year change?
Over the past year, PACB quarterly total long term liabilities has changed by -$242.03 M (-25.83%)